Psoriatic Arthritis
You have full text access to this OnlineOpen article
Prevalence of malignancy in psoriatic arthritis
Article first published online: 28 DEC 2007
DOI: 10.1002/art.23185
Copyright © 2008 by the American College of Rheumatology
Additional Information
How to Cite
Rohekar, S., Tom, B. D. M., Hassa, A., Schentag, C. T., Farewell, V. T. and Gladman, D. D. (2008), Prevalence of malignancy in psoriatic arthritis. Arthritis & Rheumatism, 58: 82–87. doi: 10.1002/art.23185
Publication History
- Issue published online: 28 DEC 2007
- Article first published online: 28 DEC 2007
- Manuscript Accepted: 7 SEP 2007
- Manuscript Received: 18 MAY 2007
- Abstract
- Article
- References
- Cited By
Cited in:
- CrossRef
This article has been cited by:
- 1, , , , , , , Cardiovascular and other comorbidities in patients with psoriatic arthritis: A comparison with patients with psoriasis, Arthritis Care & Research, 2011, 63, 12Direct Link:
- 2, , , , Large-scale, prospective, observational studies in patients with psoriasis and psoriatic arthritis: A systematic and critical review, BMC Medical Research Methodology, 2011, 11, 1, 32
- 3, , Review of Clinical Registries of Psoriatic Arthritis: Lessons Learned? Value for the Future?, Current Rheumatology Reports, 2011, 13, 4, 346
- 4
- 5, , , , , , Comorbilidades en las espondiloartropatÃas, Seminarios de la Fundación Española de ReumatologÃa, 2010, 11, 3, 89
- 6, , Managing Comorbid Disease in Patients with Psoriatic Arthritis, Current Rheumatology Reports, 2010, 12, 4, 281
- 7, , Observational cohort studies: lessons learnt from the University of Toronto Psoriatic Arthritis Program, Rheumatology, 2010, 50, 1, 25
- 8
- 9, , , , , , , , , , , , , , , , A series of critically challenging case scenarios in moderate to severe psoriasis: A Delphi consensus approach, Journal of the American Academy of Dermatology, 2009, 61, 1, S1
- 10, , Cytokine-based transformation of immune surveillance into tumor-promoting inflammation, Oncogene, 2008, 27, 45, 5913

1529-0131/asset/olbannerleft.gif?v=1&s=897b81612b4ad6cae003112184adc709261d5f61)
1529-0131/asset/olbannerright.gif?v=1&s=04654f5ea3cbb01656383e0c0d04b16fd0a9a896)
